In Vitro Selection and Characterization of Human Immunodeficiency Virus Type 1 Variants with Increased Resistance to ABT-378, a Novel Protease Inhibitor

Eitemau Tebyg

• ABT-378, a Highly Potent Inhibitor of the Human Immunodeficiency Virus Protease
  gan: Sham, Hing L., et al.
  Cyhoeddwyd: (1998)
• Selection and analysis of human immunodeficiency virus type 1 variants with increased resistance to ABT-538, a novel protease inhibitor.
  gan: Markowitz, M, et al.
  Cyhoeddwyd: (1995)
• Identification and Structural Characterization of I84C and I84A Mutations That Are Associated with High-Level Resistance to Human Immunodeficiency Virus Protease Inhibitors and Impair Viral Replication
  gan: Mo, Hongmei, et al.
  Cyhoeddwyd: (2007)
• Selection of Resistance in Protease Inhibitor-Experienced, Human Immunodeficiency Virus Type 1-Infected Subjects Failing Lopinavir- and Ritonavir-Based Therapy: Mutation Patterns and Baseline Correlates
  gan: Mo, Hongmei, et al.
  Cyhoeddwyd: (2005)
• Complementation in Cells Cotransfected with a Mixture of Wild-Type and Mutant Human Immunodeficiency Virus (HIV) Influences the Replication Capacities and Phenotypes of Mutant Variants in a Single-Cycle HIV Resistance Assay
  gan: Mo, Hongmei, et al.
  Cyhoeddwyd: (2004)